CYP4Z1 was abnormally translocated at breast cancer cell membranes and stimulated the formation of anti-CYP4Z1 autoantibodies in breast cancer patient sera in comparison with none in the control group [19,20]. This evidence concerns the gene CYP4Z1 and breast cancer.